Understanding Disease Through Immunology

Biomarker Research Paves the Road to Novel Therapies

Accelerate your biomarker research studies with pre-designed, multiplexed gene expression panels focused on Immunology and Inflammation. The nCounter® Gene Expression Panels are developed in collaboration with leading researchers to provide the most valuable and relevant panel content across applications. The nCounter® platform provides a highly multiplexed, simple workflow to enable rapid, precise, and cost-effective research with fast, reliable results; no library prep or dilutions required, with just 15-minutes total hands-on time.

Immuno-Oncology (IO) – Predictive biomarkers need to measure and integrate the complexity of host, tumor, and environment interaction. Address these key challenges in IO by measuring multi-analyte expression levels simultaneously within the tumor, the immune system, and the tumor microenvironment all on one platform with NanoString’s 3D Biology™ Technology.

Autoimmune – Biomarkers need to be evaluated for the biological variability observed in autoimmune diseases, thereby identifying predictive gene signatures. nCounter® Immunology, Inflammation and Myeloid Panels are all designed to evaluate biomarkers associated with autoimmune diseases and can be customized with up to 30 additional user-defined genes.

Infectious Disease - Accurately identify pathogens and assess the host immune response in one multiplex while tracking transcriptional profiles in vivo. nCounter® Immunology Panels are ideal for assessing infectious disease immune response and can be customized with up to 30 additional user-defined genes for pathogen identification.